Latest Lead News

Vicinity Centres confirms its distribution reinvestment plan will apply to the FY25 final distribution, offering investors a 1% discount on new securities issued under the plan.

Marquee Resources has successfully closed an oversubscribed $2.51 million placement, underscoring strong investor confidence as it prepares for the next phase of drilling at its Mt Clement Antimony Project.

Invion Limited secures a pivotal FDA Orphan Drug Designation for its lead candidate INV043, targeting anal cancer with promising preclinical results and a fast-tracked development path.

Invion Limited has disclosed that the US FDA granted Orphan Drug Designation for its lead cancer drug candidate INV043, explaining recent unusual trading activity in its shares. The company confirmed it was unaware of the FDA decision prior to its public release and has now complied with continuous disclosure rules.

Unico Silver Limited has raised $25 million through a share placement to accelerate drilling and resource upgrades at its key silver projects in Argentina, aiming to define a major silver equivalent resource.

Neurizon Therapeutics reports encouraging topline results from its Phase 1 Open-Label Extension study of NUZ-001, demonstrating long-term safety and a significant survival advantage in ALS patients. These findings pave the way for the pivotal HEALEY ALS Platform Trial planned for late 2025.

Felix Group Holdings has completed a fully underwritten A$16 million placement at a premium, aiming to acquire Nexvia and boost its SaaS platform expansion. A follow-up Share Purchase Plan will offer existing shareholders a chance to participate.

Wia Gold Limited has raised A$30 million through a placement to fund accelerated exploration and development at its Kokoseb gold project in Namibia, bolstering its cash position to approximately A$55 million.

Vicinity Centres confirms its distribution reinvestment plan will apply to the FY25 final distribution with a 1% discount on new securities, inviting investors to reinvest dividends under favourable terms.

RocketBoots Limited has secured a significant trial contract with one of Mexico's largest retail banks, marking a key step in its international expansion and potential revenue growth.

LTR Pharma’s intranasal ED treatment SPONTAN achieves peak effect up to five times faster than oral tablets, according to new peer-reviewed clinical data published in a leading European journal.

Xamble Group Limited is accelerating its transformation into Southeast Asia’s premier influencer marketing platform, reporting strong H1 revenue growth and launching a strategic rights issue to fund expansion and technology upgrades.